| Literature DB >> 28657672 |
Abbas Mohammadpour-Gharehbagh1,2, Saeedeh Salimi1,2, Farshid Keshavarzi1,2, Foozieh Saeidian1, Mahdieh Mousavi3, Batool Teimoori4,5, Maryam Esmaeilipour4, Mojgan Mokhtari6.
Abstract
Preeclampsia (PE) as a pregnancy-specific disorder is the major cause of mortality and morbidity of mothers and fetuses. This study attempts to investigate the possible association between the 2572C>A (rs4846049) and 4869C>G (rs1537514) polymorphisms in the 3'- untranslated region of MTHFR gene and the risk of PE. A total of 198 patients diagnosed with PE and 171 unrelated, age matched healthy pregnant women, were recruited for this case-control study. The MTHFR 2572C>A and 4869C>G genotyping was performed by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The CG genotype of MTHFR 4869C>G was associated with decreased risk of PE, and this genotype was found to be a protective factor for PE susceptibility. There was no significant difference in the genotypes of MTHFR 2572C>A polymorphism between PE patients and control group. The frequency of combined AC/CG genotypes of MTHFR 2572C>A and 4869C>G polymorphisms were less frequent in PE patients and were associated with a lower risk of PE. The C-G and A-G haplotypes of MTHFR 2572C>A and 4869C>G polymorphisms were significantly lower in PE patients. In conclusion, the CG genotype of MTHFR 4869C>G polymorphism was associated with a lower risk of PE. No association was found between MTHFR 2572C>A polymorphism and PE.Entities:
Keywords: MTHFR; haplotype; in silico analysis; polymorphism; preeclampsia
Mesh:
Substances:
Year: 2017 PMID: 28657672 DOI: 10.1002/jcb.26240
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429